Research on Neutricks®
Apoaequorin research is conducted with Quincy Bioscience, with academic laboratories, and other research institutions such as CanCog Technologies, a leader in cognitive research.
The company's interests are in calcium metabolism and homeostasis throughout companion animal physiology. Research efforts of apoaequorin are two-fold; first, to evaluate the effectiveness of apoaequorin, a protein, to support cells, and second, to evaluate the effectiveness of apoaequorin in supporting the mild memory problems of aging in companion animals.
Figure 1. Baseline Performance on the DNMP. Each animal was given 30 trials at each delay over 5 baseline sessions. The y-axis indicates total correct responses at each delay.
Figure 2. Effect of Apoaequorin on two different measures of performance on the discrimination learning task. The top shows the effect on errors to criterion measure of learning. The bottom shows percent correct for each of the groups.
Figure 3. Performance on the attention task as a function of number of distractors. The data reflect combined data from all three groups.
Figure 4. Performance on the attention task as a function of number of distractors and treatment condition.
Figure 5. Latency as a function of treatment and number of distractors, independently of response accuracy.
Figure 6. Latency as a function of accuracy, number of distractors
Figure 7. Accuracy as a function of delay at baseline and when retested in the treatment phase. The data shown are the combined data for all of the groups.
Figure 8. Percent correct on DNMP under baseline and test conditions as function of treatment. The percent correct score was calculated by combining performance at all delays.